Literature DB >> 4396864

Preliminary studies of the pharmacological effects of 5-[1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)-ethyl] salicylamide (AH 5158) in man.

A J Boakes, E J Knight, B N Prichard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4396864     DOI: 10.1042/cs040018pa

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  10 in total

1.  Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.

Authors:  D A Richards; J Tuckman; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.

Authors:  C Skinner; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1975-04-12

Review 3.  Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.

Authors:  W H Frishman
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

Review 4.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.

Authors:  I Kennedy; G P Levy
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

6.  Cold sensitivity in essential hypertension: the effect of beta- and combined alpha- and beta-blockade.

Authors:  E D Cooke; S A Bowcock; A T Smith
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

8.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

9.  Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

10.  Comparison of labetalol and clonidine in hypertension.

Authors:  M Lilja; A J Jounela; H Karppanen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.